Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

NCT01135329 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped The stopping rule was met and hence the study was closed

Conditions

Lymphoma
Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: Fludarabine
DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins